Stills Disease Treatment Market, By Type (Non-Steroidal Anti-Inflammatory Drugs, Corticosteroids, Disease-Modifying Antirheumatic Drugs, and Biologics), By Route of Administration, By Patient Age Group, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5502
|
Published Date
June 2026
|
Pages
364
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Stills Disease Treatment Market size was valued at US$ 3,105.9 Million in 2025, expanding at a CAGR of 5.2% from 2026 to 2033.
The Still’s disease treatment industry focuses on the development and supply of therapeutic solutions for Still’s disease, a rare inflammatory condition characterized by persistent fever, joint pain, and skin rash. Management of adult-onset Still’s disease typically involves a combination of anti-inflammatory drugs, corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and biologic therapies, aimed at controlling inflammation and preventing long-term complications. Treatment approaches continue to evolve as research advances, with an increasing shift toward targeted therapies that improve disease control, reduce flare-ups, and enhance patient quality of life.
The growing global burden of chronic and rare inflammatory diseases is also supporting market development. According to the World Health Organization (WHO), musculoskeletal conditions affect approximately 1.7 billion people worldwide, making them one of the leading causes of disability globally. This rising disease burden, along with advancements in precision medicine and biologic drug development, is expected to further strengthen demand for innovative treatment options in the Still’s disease therapeutics market.
Stills Disease Treatment Market- Market Dynamics
Increasing Adoption of Combination Therapy Approaches Driving Market Growth
The increasing demand for combination therapies is a key factor driving growth in the Still’s disease treatment market, as clinicians seek more effective approaches to manage diverse inflammatory symptoms and reduce the frequency of disease flare-ups. Combination treatment strategies allow for improved disease control by targeting multiple inflammatory pathways simultaneously, leading to better patient outcomes and more sustained remission. According to the Association of the British Pharmaceutical Industry (ABPI), the clinical importance of combination therapies has significantly accelerated pharmaceutical research activity. In March 2026, it was reported that approximately 50% of oncology drug development pipelines involve combination treatment approaches, reflecting a strong industry shift toward multi-targeted therapeutic strategies. This growing emphasis on combination therapies is expected to enhance treatment effectiveness and support the continued expansion of the Still’s disease treatment market.
Stills Disease Treatment Market- Segmentation Analysis:
The Global Stills Disease Treatment Market is segmented on the basis of Type, Route of Administration, Patient Age Group, End User, and Region.
In the Still’s disease treatment market, corticosteroids account for a significant share within the type segment due to their rapid anti-inflammatory effects, which help reduce fever, joint pain, and other acute symptoms. They are commonly used as first-line therapy to manage disease flare-ups and provide quick symptomatic relief in patients. Their effectiveness in controlling inflammation has made them a mainstay in the management of autoimmune and inflammatory conditions. According to the U.S. National Institutes of Health (NIH), the widespread use of corticosteroids continues to highlight their importance in treating inflammatory and immune-mediated disorders. A study covering 1,471 general practices in England reported that 1,375,099 patients were treated with oral corticosteroids, 140,078 received injectable forms, and 912,454 used inhaled corticosteroids. This extensive utilization underscores the critical role corticosteroids play in managing inflammatory diseases, including Still’s disease.
From the perspective of patient age groups, adults represent a major segment in the Still’s disease treatment market, primarily due to the higher incidence of adult-onset Still’s disease, increased diagnosis rates, and the need for long-term disease management to prevent complications. In March 2025, Swedish Orphan Biovitrum AB (Sobi) reported a rising adoption of the IL-1 receptor antagonist therapy Kineret® (anakinra) for adult Still’s disease patients, reflecting the growing importance of targeted biologic treatments in addressing adult patient needs. This trend highlights the continued shift toward advanced therapies aimed at improving long-term outcomes in adult populations.
Stills Disease Treatment Market- Geographical Insights
There is growing demand for Still’s disease therapies in North America, supported by the region’s advanced healthcare infrastructure and expanding access to specialized treatment services. Increased patient awareness, improved diagnostic capabilities, and the availability of advanced biologic therapies are further contributing to higher treatment uptake across the region. According to a Canadian study published in the International Journal of Health Policy and Management (2025), waiting times for specialist care are projected to increase from 25.6 weeks to 27.4 weeks, reflecting rising demand for healthcare services. The study also noted that the Government of Canada has invested approximately USD 196.1 billion over a 10-year period to expand healthcare system capacity and support the adoption of digital and virtual care solutions. These ongoing investments in healthcare infrastructure and service delivery are expected to strengthen treatment accessibility and support the continued growth of the Still’s disease treatment market across North America.
Stills Disease Treatment Market- Competitive Landscape:
The Still’s disease treatment market is witnessing significant advancements, driven by a growing focus on innovative therapeutic approaches for this rare inflammatory condition. Increasing research activity and the development of targeted biologics and immunology-based therapies are shaping the competitive landscape. Key market participants such as Novartis AG, F. Hoffmann-La Roche Ltd, Swedish Orphan Biovitrum AB (Sobi), Sanofi S.A., and Regeneron Pharmaceuticals Inc. are strengthening their positions through continuous innovation, strategic initiatives, and diversified immunology-focused product portfolios within this niche therapeutic area. In June 2026, F. Hoffmann-La Roche Ltd entered into a partnership and licensing agreement with Nurix Therapeutics for the development and commercialization of bexobrutinib, a novel BTK degrader designed for the treatment of immune-mediated disorders. This collaboration reflects Roche’s ongoing strategy to expand its immunology pipeline through innovative drug development approaches.
Recent Developments
- In April 2025, Amgen Inc. achieved a regulatory milestone with the approval of UPLIZNA® (inebilizumab-cdon) for an immune-mediated inflammatory disorder, further advancing its CD19-targeted platform and expanding its portfolio of biologic therapies for rare autoimmune diseases.
- In March 2025, Sanofi S.A. acquired Dren Bio’s immunology affiliate, Dren-0201, to accelerate the development of an investigational therapy for autoimmune diseases. This acquisition strengthened Sanofi’s immunology capabilities and reinforced its commitment to expanding treatment options for immune-mediated conditions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL STILLS DISEASE TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Swedish Orphan Biovitrum AB (Sobi)
- Sanofi S.A.
- Regeneron Pharmaceuticals Inc.
- AbbVie Inc.
- Johnson & Johnson
- Pfizer Inc.
- Amgen Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb
- GSK (GlaxoSmithKline)Others
GLOBAL STILLS DISEASE TREATMENT MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Non-Steroidal Anti-Inflammatory Drugs
- Corticosteroids
- Disease-Modifying Antirheumatic Drugs
- Biologics
GLOBAL STILLS DISEASE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033
- Oral
- Intravenous
- Subcutaneous
GLOBAL STILLS DISEASE TREATMENT MARKET, BY PATIENT AGE GROUP- MARKET ANALYSIS, 2020 - 2033
- Pediatric
- Adult
GLOBAL STILLS DISEASE TREATMENT MARKET, BY END USER - MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Clinics
- Homecare Settings
- Others
GLOBAL STILLS DISEASE TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Stills Disease Treatment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Stills Disease Treatment Market Snippet by Type
2.1.2. Stills Disease Treatment Market Snippet by Route of Administration
2.1.3. Stills Disease Treatment Market Snippet by Patient Age Group
2.1.4. Stills Disease Treatment Market Snippet by End User
2.1.5. Stills Disease Treatment Market Snippet by Country
2.1.6. Stills Disease Treatment Market Snippet by Region
2.2. Competitive Insights
3. Stills Disease Treatment Key Market Trends
3.1. Stills Disease Treatment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Stills Disease Treatment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Stills Disease Treatment Market Opportunities
3.4. Stills Disease Treatment Market Future Trends
4. Stills Disease Treatment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Stills Disease Treatment Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Stills Disease Treatment Market Landscape
6.1. Stills Disease Treatment Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Stills Disease Treatment Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
7.1.2. Non-Steroidal Anti-Inflammatory Drugs
7.1.3. Corticosteroids
7.1.4. Disease-Modifying Antirheumatic Drugs
7.1.5. Biologics
8. Stills Disease Treatment Market – By Route of Administration
8.1. Overview
8.1.1. Segment Share Analysis, By Route of Administration, 2025 & 2033 (%)
8.1.2. Oral
8.1.3. Intravenous
8.1.4. Subcutaneous
9. Stills Disease Treatment Market – By Patient Age Group
9.1. Overview
9.1.1. Segment Share Analysis, By Patient Age Group, 2025 & 2033 (%)
9.1.2. Paediatric
9.1.3. Adult
10. Stills Disease Treatment Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
10.1.2. Hospitals
10.1.3. Clinics
10.1.4. Homecare Settings
10.1.5. Others
11. Stills Disease Treatment Market – By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Stills Disease Treatment Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Stills Disease Treatment Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Stills Disease Treatment Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Stills Disease Treatment Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Stills Disease Treatment Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Patient Age Group, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Stills Disease Treatment Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Novartis AG
12.2.2. F. Hoffmann-La Roche Ltd
12.2.3. Swedish Orphan Biovitrum AB (Sobi)
12.2.4. Sanofi S.A.
12.2.5. Regeneron Pharmaceuticals Inc.
12.2.6. AbbVie Inc.
12.2.7. Johnson & Johnson
12.2.8. Pfizer Inc.
12.2.9. Amgen Inc.
12.2.10. Eli Lilly and Company
12.2.11. Bristol-Myers Squibb
12.2.12. GSK (GlaxoSmithKline)
12.2.13. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL STILLS DISEASE TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Swedish Orphan Biovitrum AB (Sobi)
- Sanofi S.A.
- Regeneron Pharmaceuticals Inc.
- AbbVie Inc.
- Johnson & Johnson
- Pfizer Inc.
- Amgen Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb
- GSK (GlaxoSmithKline)Others
GLOBAL STILLS DISEASE TREATMENT MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Non-Steroidal Anti-Inflammatory Drugs
- Corticosteroids
- Disease-Modifying Antirheumatic Drugs
- Biologics
GLOBAL STILLS DISEASE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033
- Oral
- Intravenous
- Subcutaneous
GLOBAL STILLS DISEASE TREATMENT MARKET, BY PATIENT AGE GROUP- MARKET ANALYSIS, 2020 - 2033
- Pediatric
- Adult
GLOBAL STILLS DISEASE TREATMENT MARKET, BY END USER - MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Clinics
- Homecare Settings
- Others
GLOBAL STILLS DISEASE TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
